Back
Astrana Health, Inc. 10K Form
Sell
29
ASTH
Astrana Health, Inc.
Last Price:
$22.7700
Seasonality Move:
21.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ASTH News And Ratings
See the #1 stock for the next 7 days that we like better than ASTH
ASTH Financial Statistics
Sales & Book Value
| Annual Sales: | $2B |
|---|---|
| Cash Flow: | $7.4M |
| Price / Cash Flow: | 11.5 |
| Annual Sales: | $15.70 |
| Price / Book: | 1.47 |
Profitability
| EPS (TTM): | 0.19000 |
|---|---|
| Net Income (TTM): | $9.7M |
| Gross Margin: | $243.5M |
| Return on Equity: | 1.85% |
| Return on Assets: | 0.64% |
Astrana Health, Inc. Earnings Forecast
Key Astrana Health, Inc. Financial Ratios
-
The Gross Profit Margin over the past 27 years for ASTH is 11.97%.
-
The Selling, General & Administrative Expenses for ASTH have been equal to 7.57% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 66.28% of Operating Income.
-
The Net Earning history of ASTH is 2.45% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 13 years.
Astrana Health, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | ASTH |
| Website: | astranahealth.com |
Debt
| Debt-to-Equity Ratio: | 1.4 |
|---|---|
| Current Ratio: | 1.4 |
| Quick Ratio: | 1.34 |
Price-to-Earnings
| Trailing P/E Ratio: | 25.34 |
|---|---|
| Forward P/E Ratio: | 10.22 |
ASTH Technical Analysis vs Fundamental Analysis
Sell
29
Astrana Health, Inc. (ASTH)
is a Sell
Is Astrana Health, Inc. a Buy or a Sell?
-
Astrana Health, Inc. stock is rated a SellThe current Astrana Health, Inc. [ASTH] share price is $22.7900. The Score for ASTH is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.